Effect of HMR 3339, a novel selective estrogen receptor modulator, on C-reactive protein levels in healthy postmenopausal women

被引：10

作者：

Vogelvang, TE

Mijatovic, V

Kenemans, P

Schalkwijk, CG

van der Mooren, MJ

机构：

[1] Vrije Univ Amsterdam, Med Ctr, Dept Obstet & Gynecol, ICaR, NL-1007 MB Amsterdam, Netherlands

[2] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, ICaR, NL-1007 MB Amsterdam, Netherlands

[3] Vrije Univ Amsterdam, Med Ctr, Project Aging Women, NL-1007 MB Amsterdam, Netherlands

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 09期

关键词：

D O I：

10.1016/j.amjcard.2004.07.099

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We investigated the 12-week effects of 3 doses of HMR 3339, a novel selective estrogen receptor modulator, in comparison with raloxifene and placebo, on plasma concentrations of C-reactive protein in 96 healthy postmenopausal women. A dose-dependent reduction in C-reactive protein was observed, the largest reduction with HMR 3339 50 mg. (C) 2004 by Excerpta Medica, Inc.

引用

页码：1205 / 1208

页数：4

共 50 条

[1] HMR 3339, a novel selective estrogen receptor modulator, reduces total cholesterol, low-density lipoprotein cholesterol, and homocysteine in healthy postmenopausal women
Vogelvang, TE
Mijatovic, V
Kenemans, P
Teerlink, T
van der Mooren, MJ
[J]. FERTILITY AND STERILITY, 2004, 82 (06) : 1540 - 1549
[2] HMR 3339, a novel selective estrogen receptor modulator, reduces concentrations of procarboxypeptidase U, an inhibitor of fibrinolysis. A randomized, placebo-controlled study in postmenopausal women
Vogelvang, TE
Leurs, JR
Mijatovic, V
Willemse, J
Van der Mooren, MJ
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (05) : 1090 - 1092
[3] The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: A randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women
Vogelvang, TE
Mijatovic, V
Kenemans, P
Emeis, JJ
Heijst, JA
van der Mooren, MJ
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (04) : 1384 - 1394
[4] Effects on asymmetric dimethylarginine of HMR 3339, a novel selective estrogen receptor modulator: a 12-week, randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women
Verhoeven, Marieke O.
Teerlink, Tom
Kenemans, Peter
Vogelvang, Tatjana E.
van der Mooren, Marius J.
[J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (02): : 235 - 242
[5] Effect Of Abdominal And Total Fat On C-reactive Protein Levels In Postmenopausal Women
Wright, Jennifer
Stanescu, Claudia I.
Cussler, Ellen C.
Williams, Daniel P.
Going, Scott B.
Lohman, Timothy G.
Bartell-Weiss, Lauren
[J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2005, 37 : S303 - S304
[6] Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women
Herrington, DM
Pusser, BE
Riley, WA
Thuren, TY
Brosnihan, KB
Brinton, EA
MacLean, DB
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) : 1606 - 1612
[7] Augmentation Index is Not Related to C-Reactive Protein in Healthy Postmenopausal Women
Roy, Matthew S.
Edwards, David G.
[J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2006, 38 (05): : S186 - S186
[8] Endogenous sex hormones and C-reactive protein in healthy postmenopausal women
Stoerk, S.
Bots, M. L.
Grobbee, D. E.
van der Schouw, Y. T.
[J]. JOURNAL OF INTERNAL MEDICINE, 2008, 264 (03) : 245 - 253
[9] Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: Comparison between oral and transdermal administration of estrogen
Modena, MG
Bursi, F
Fantini, G
Cagnacci, A
Carbonieri, A
Fortuna, A
Rossi, R
[J]. AMERICAN JOURNAL OF MEDICINE, 2002, 113 (04): : 331 - 333
[10] A new selective estrogen receptor modulator HMR-3339 fully corrects bone alterations induced by ovariectomy in adult rats
Ammann, P
Bourrin, S
Brunner, F
Meyer, JM
Clément-Lacroix, P
Baron, R
Gaillard, M
Rizzoli, R
[J]. BONE, 2004, 35 (01) : 153 - 161

← 1 2 3 4 5 →